Multicenter Experience with Maxillary Prostheses Supported by Brånemark Implants: A Clinical Report
Koichiro Ihara, DDS, Masaaki Goto, DDS, PhD, Akira Miyahara, DDS, Junichiro Toyota, DDS, Takeshi Katsuki, DDS, PhD.
This retrospective study involved Japanese patients with prostheses supported by Brånemark implants following maxillectomy. Questionnaires were sent to 75 institutions, and data on 19 patients were collected from 8 institutions. The mean age of patients at the time of implant placement was 64.2 years (range 22 to 82 years). The mean follow-up time was 27.6 months. Of the 81 implants placed, 16 were lost for an implant survival rate of 80.2%. The effects on implant survival rate of radiotherapy, chemotherapy, hyperbaric oxygen therapy, and the support system of the prosthesis were analyzed, but no significant differences were observed. (INT J ORAL MAXILLOFAC IMPLANTS 1998;13:531–538) Key words: Brånemark implants, chemotherapy, maxillary prostheses, maxillary tumor, multicenter study, radiotherapy, survival rate